Search

Zimmer Biomet Holdings Inc

Open

SectorGezondheidszorg

95.59 -0.94

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

94.16

Max

96.98

Belangrijke statistieken

By Trading Economics

Inkomsten

99M

239M

Verkoop

-157M

2.1B

K/W

Sectorgemiddelde

23.852

64.641

EPS

2.09

Dividendrendement

1.05

Winstmarge

11.43

Werknemers

17,000

EBITDA

84M

538M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+2.66% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

1.05%

2.31%

Volgende Winsten

5 aug 2026

Volgende dividenddatum

30 okt 2026

Volgende Ex Dividend datum

29 sep 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-110M

18B

Vorige openingsprijs

96.53

Vorige sluitingsprijs

95.59

Nieuwssentiment

By Acuity

31%

69%

97 / 340 Rangschikking in Healthcare

Zimmer Biomet Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

3 aug 2026, 23:11 UTC

Shares of Zimmer Biomet Holdings Inc. are lower in after-market hours, showing weakness despite earlier gains and remaining above their 20-day moving average.

31 jul 2026, 20:06 UTC

Correlated Moves

Zimmer Biomet Holdings Inc. shares are lower today, influenced by Stryker Corp's decline and broader market sentiment amid rising Treasury yields and inflation concerns.

30 jul 2026, 19:03 UTC

Zimmer Biomet Holdings Inc shares are lower today, breaking a trend of higher closes. Broader economic indicators may contribute to market uncertainty.

29 jul 2026, 17:46 UTC

Zimmer Biomet Holdings Inc shares are higher, continuing a positive trend since Tuesday's close. Broader market volatility is impacting sentiment amid rising oil prices.

28 jul 2026, 20:03 UTC

News
Social Media

UBS initiated coverage on Zimmer Biomet with a Buy rating and a $115 price target, supporting shares' advance during the current trading session.

27 jul 2026, 18:46 UTC

Correlated Moves

Zimmer Biomet Holdings Inc is advancing in Monday's session, supported by a broader rise in the medical devices sector amid declining crude oil prices.

24 jul 2026, 19:06 UTC

Correlated Moves

Zimmer Biomet Holdings is trading higher, benefiting from a pullback in crude oil prices and positive sentiment in the health care equipment sector.

23 jul 2026, 21:02 UTC

Zimmer Biomet Holdings Inc shares are lower in after-market hours. No specific news was identified to explain the price movement.

22 jul 2026, 18:36 UTC

Correlated Moves

Zimmer Biomet Holdings Inc reported first-quarter adjusted EPS of $1.08, below estimates. Shares are lower today amid broader sector declines and external market pressures.

20 jul 2026, 18:16 UTC

Zimmer Biomet Holdings Inc shares are lower amid unusual volatility and broader market concerns over rising yields and inflation fears linked to increasing oil prices.

Peer Vergelijking

Prijswijziging

Zimmer Biomet Holdings Inc Prognose

Koersdoel

By TipRanks

2.66% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 99.56 USD  2.66%

Hoogste 115 USD

Laagste 83 USD

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor Zimmer Biomet Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

10 ratings

4

Buy

6

Hold

0

Sell

Sentiment

By Acuity

97 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.
help-icon Live chat